AI assistant
Natco Pharma Ltd. — Call Transcript 2019
Aug 2, 2019
62741_rns_2019-08-02_79050107-b5ac-44b7-84cf-852a82502257.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [452 x 46] intentionally omitted <==
August 2, 2019
Corporate Relationship Department M/s. BSE Limited Dalal Street, Fort, Mumbai 400 001
Manager - Listing M/s. National Stock Exchange of India Ltd “Exchange Plaza, Bandra – kurla complex, Bandra (E), Mumbai 400 051
Scrip Code: 524816
Scrip Code: NATCOPHARM
Dear Sir
Sub: - Earning call for Q1FY20
The Company will host an Earnings Call with Investors / Analysts at 3.30 p.m. IST on August 9, 2019 to disseminate Financial Results of the company for the quarter ended June 30, 2019. A Copy of the same is enclosed for your ready reference.
Thanking you
Yours faithfully For NATCO Pharma Limited
==> picture [106 x 23] intentionally omitted <==
M Adinarayana Company Secretary & Vice President (Legal & Corp. Affairs)
Encl: as above.
CONFERENCE CALL
NATCO PHARMA
Hosted by Edelweiss Securities
India Equity Research Aug 02, 2019
We are organising a conference call with the management of NATCO Pharma, to discuss the company’s Q1FY20 financial results on Friday, August 9, 2019 at 3.30 p.m IST.
Mr. Rajeev Nannapaneni (Vice Chairman and Chief Executive Officer) and Mr. Rajesh Chebiyam (Vice President, Acquisitions, Institutional Investor Management and Corporate Communications) will represent NATCO Pharma on the call. The call would run for an hour.
Details of the conference call are as under:
| Time:3.30 PM IST on Friday, August 9, 2019 | Time:3.30 PM IST on Friday, August 9, 2019 | Time:3.30 PM IST on Friday, August 9, 2019 | Time:3.30 PM IST on Friday, August 9, 2019 | Time:3.30 PM IST on Friday, August 9, 2019 |
|---|---|---|---|---|
| Conference dial-in: | ||||
| India | :Mumbai | |||
| Primary access number | +91 22 628 | 0 1123 | ||
| +91 22 71 | 15 8024 | |||
| USA | : | 1 866 746 | 2133 | |
| UK | : | 0 808 101 | 1573 | |
| Singap | re Toll Free No | : | 800 101 20 | 45 |
| . | ||||
| Hong K | 8 | |||
| ong Toll Free No. | : | 800 964 44 | ||
| Call lea | ||||
| der | Mr. Deepak Malik | |||
For further information please contact:
Deepak Malik
Edelweiss Securities Ltd. Tel.: +91 22 6620 3147 Fax: +91 22 2286 4310 E-mail: [email protected]
Edelweiss Research is also available on www.edelresearch.com, 1 Bloomberg EDEL , Thomson First Call, Reuters and Factset.
LimitedLimited